As an illustration, multiomics analysis unveiled MUC16 and SLC24A2 as potential driver genes in bladder cancer, while high expression levels of these genes were significantly linked to a shorter survival period, suggesting their potential as therapeutic targets (supplementary fig. The gene discussed is MUC16; the disease is urinary bladder carcinoma.